Sanofi Consumer Healthcare India Ltd
- Market Cap ₹ 11,062 Cr.
- Current Price ₹ 4,803
- High / Low ₹ 5,499 / 4,212
- Stock P/E 54.9
- Book Value ₹ 119
- Dividend Yield 1.15 %
- ROCE 189 %
- ROE 147 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 40.5 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational
Part of BSE Allcap BSE Healthcare Nifty Microcap 250 Nifty Total Market BSE SmallCap
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Dec 2023 | Dec 2024 | |
---|---|---|
0 | 724 | |
0 | 454 | |
Operating Profit | -0 | 271 |
OPM % | 37% | |
0 | -15 | |
Interest | 0 | 4 |
Depreciation | 0 | 4 |
Profit before tax | -0 | 247 |
Tax % | 0% | 27% |
-0 | 181 | |
EPS in Rs | 78.59 | |
Dividend Payout % | 0% | 70% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 67230% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 147% |
Balance Sheet
Figures in Rs. Crores
Dec 2023 | Dec 2024 | |
---|---|---|
Equity Capital | 2 | 23 |
Reserves | -0 | 250 |
0 | 20 | |
0 | 138 | |
Total Liabilities | 2 | 431 |
0 | 29 | |
CWIP | 0 | 1 |
Investments | 0 | 0 |
2 | 402 | |
Total Assets | 2 | 431 |
Cash Flows
Figures in Rs. Crores
Dec 2023 | Dec 2024 | |
---|---|---|
-0 | 439 | |
0 | 2 | |
2 | -116 | |
Net Cash Flow | 2 | 325 |
Ratios
Figures in Rs. Crores
Dec 2023 | Dec 2024 | |
---|---|---|
Debtor Days | 7 | |
Inventory Days | 80 | |
Days Payable | 138 | |
Cash Conversion Cycle | -51 | |
Working Capital Days | -31 | |
ROCE % | 189% |
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
30 Mar - Approval of director appointment and related party transactions.
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
30 Mar - Approval of director appointment and related party transactions.
- Closure of Trading Window 27 Mar
-
Intimation Of Second (2Nd) Annual General Meeting Of The Company
27 Mar - Intimation of 2nd Annual General Meeting on 5th May 2025.
-
Newspaper Publication - Annual General Meeting Through Video Conferencing Facility
25 Mar - Copies of newspaper publication related to notice of Annual General Meeting which will be held through VC facility on 5th May 2025, published today in …
Annual reports
No data available.